Aprepitant and granisetron for the prophylaxis of radiotherapy-induced nausea and vomiting after moderately emetogenic radiotherapy for bone metastases: a prospective pilot study.

Dennis, K

Aprepitant and granisetron for the prophylaxis of radiotherapy-induced nausea and vomiting after moderately emetogenic radiotherapy for bone metastases: a prospective pilot study. [electronic resource] - Current oncology (Toronto, Ont.) Dec 2014 - e760-7 p. digital

Publication Type: Journal Article

1198-0052

10.3747/co.21.2051 doi